1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Seven people look for bargains to buy at a yard sale.
    Cheap Shares

    7 oversold ASX shares to buy in November 2023

    | Motley Fool Staff

    With great market falls often come great buying opportunities...

    Read more »

    Man sits smiling at a computer showing graphs
    Broker Notes

    Citi says CSL shares can rise almost 40%

    | James Mickleboro

    Big returns could be on offer with this beaten down biotherapeutics giant's shares.

    Read more »

    Shot of a scientist recording his findings on a digital tablet.
    Healthcare Shares

    Will I look back and regret not buying CSL shares at $237 today?

    | Bernd Struben

    Is buying CSL shares today akin to catching a falling knife? Or will I regret not buying the healthcare stock…

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    'Wave of innovation': Why ASX 200 healthcare shares are poised for new growth

    | Bernd Struben

    After struggling in 2023, Janus Henderson Investors says the healthcare sector’s long-term outlook appears stronger than ever.

    Read more »

    Woman flexes muscles after donating blood.
    Healthcare Shares

    Why Ozempic shouldn't ruin an appetite for CSL shares

    | Mitchell Lawler

    Could CSL be immune to Ozempic's expanding range of uses.

    Read more »

    Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave the thumbs up to these ASX shares last week. Why are they bullish?

    Read more »

    A man in a business suit uses a rope to climb up the side of a huge pile of papers fashioned like a tall building against a blue sky backdrop with clouds representing an assessment of whether CBA shares stacked up well in March
    Share Market News

    Here's how the ASX 200 market sectors stacked up this week

    | Bronwyn Allen

    The ASX 200 lifted 0.9% this week, with the best performing sector being utilities.

    Read more »

    An older woman wearing a party hat is giving a thumbs up, but she's not happy about it.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Do you own any of the rare ASX 200 winners from today?

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Shot of a mature scientists working on a laptop in a lab.
    Healthcare Shares

    The CSL share price just hit a multi-year low, is it time to buy?

    | Tristan Harrison

    The healthcare giant is suffering a loss of investor confidence.

    Read more »

    Shot of a young scientist looking stressed out while working on a computer in a lab.
    Healthcare Shares

    Ozempic sell-off: What is Goldman saying about CSL and ResMed shares?

    | James Mickleboro

    CSL and ResMed shares were hammered yesterday. Was it an overreaction?

    Read more »

    A group of business executives shake hands in a lounge.
    Energy Shares

    AGL share price lifts amid new power deal with biotech giant

    | Bronwyn Allen

    Renewable energy certificates are part of the deal.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note